Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04663087 · ClinicalTrials.gov registry record · NA
Feasibility of Evaluating XSTAT Use in the Prehospital Setting
A NA study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04663087 is a NA study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 1 participants.
The verdict
NCT04663087, a NA study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study evaluates the prehospital use of the XSTAT device to control bleeding in junctional wounds. Participants will be randomized to the use of XSTAT versus standard care.
Interventions
- OTHER Standard of Care
- DEVICE XSTAT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-10-29 |
| Est. Completion | 2023-08-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04663087
The ClinicalTrials.gov registry entry for NCT04663087 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04663087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04663087 about?
NCT04663087 is a clinical study titled "Feasibility of Evaluating XSTAT Use in the Prehospital Setting". This study evaluates the prehospital use of the XSTAT device to control bleeding in junctional wounds. Participants will be randomized to the use of XSTAT versus standard care.
What is the current status of trial NCT04663087?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-10-29. Estimated completion is 2023-08-11.
What interventions are being tested in trial NCT04663087?
The interventions under investigation include: Standard of Care (OTHER), XSTAT (DEVICE).
Who is sponsoring clinical trial NCT04663087?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.